What is known about the medicinal plants
1. Current domestic & international markets are large:
• 80% of worlds population uses medicinal plants
• 25% of prescribed drugs contain plant ingredients
• Global trade > USD 500 bln in 2000 2. Demand for medicinal plants to produce 3 kinds of product:
• Allopathic medicines
• Herbal remedies
• Crude traditional medicines Allopathic medicines
• Formally produced & recognised products, often a result of
• Phytomedicines, cosmeceuticals, nutraceuticals etc
• Traded on the formal market through established commercial
• Source raw materials from farms / the wild (harvesters)
Herbal remedies
• Traded in formal & informal markets through large & small
• Raw materials sourced from the wild & small farms
o Benefit sharing / returns to entrepreneurs
Crude traditional medicines
• Prepared & sold by traditional healers
• Raw plant materials, basic mixes & semi-processed products
• Raw materials sourced from the wild or home gardens
Trade & Commercialisation Opportunities
International Markets
• Europe imports 132,000 T – 20% from Africa
• Asia: 700,000 T used in China (China & India ss)
• US imports 200,000 T - (China & India ss)
• Significant intra-Africa trade Southern African plants being exported: Aloe ferox, Prunus africana, Cassia spp., Harpagophytum
Trade & Commercialisation OpportunitiesCrude Traditional Medicines
Market in southern Africa is increasing -
• HIV/AIDS & increasing urbanisation 455,000 Traditional Healers in southern Africa Estimated 50,000T / a consumed Informal trade – seem to be opportunities for increasing trade & returns Options may be limited because of certain constraints Consumer preferences - little is known An overwhelming majority of consumers would prefer more modern & hygienic packaging & that traditional medicines should be certified
Trade & Commercialisation OpportunitiesHerbal RemediesMarket is growing globally
Opportunities for product development, domestic trade & export
Few commercial companies have penetrated traditional healthcare market
Market for African herbal preparations small, potential unknown
Demand for individual products known - broader market?
Market for African herbal products in Europe, local companies already trading raw / processed products into these countries
Quality & production standards for products exported to Europe are high
Trade & Commercialisation OpportunitiesAllopathic Medicines
Bioprospecting e.g. Hoodia & Hypoxis; significant investment required for drug development
Large commercial companies likely to pursue business opportunities
Access & benefit sharing will become important means of securing economic & social benefits
International market for southern African plants underpinned bioprospecting & plant research
Market specific about products - processed form & chemical constituents of raw materials
Critical that the producer fully understands the specifications of the buyer before investing in the production system
Market Opportunities for Plant Cultivation
Much of the potential for market growth in the medicinal plants sector is limited by supply constraints
These would be eliminated if the medicinal plants were successfully cultivated. Increased supply of rare plants that are in high demand would almost certainly bring about market growth
BUT increases in raw material supply can affect pricing and havea negative affect on the market as a result
An increased and more consistent supply of good quality plant material would allow more advanced processing to take place
Other Opportunities for TradeFair TradeAims to secure a better deal for producers by setting stable product prices that cover costs plus a premium
Promotes access to markets for producers marginalised by conventional trading structures
Many African producers & production systems face a range of logistical difficulties that can alienate them from sophisticated / high-volume markets
Limits opportunities for rural producers to engage markets in developed countries - products are priced incorrectly, product is not of adequate quality, or sufficient quantity cannot be produced
Fair Trade presents a real opportunity for linking rural production enterprises to sophisticated markets through trade and pricing agreements
BUT no standards for medicinal plant products
Other Opportunities for the TradeCertification
Sustainable production / sourcing certification
Some of these require development of standards specific to medicinal plants industry & establishment of certification organisations
BUT production systems / certification procedures may be sophisticated – limited portion of the trade could engage
Presents a clear advantage for future trade into developed markets SO need to start thinking about which certification systems would work, where & how
Need to IMPLEMENT sustainable supply systems – for supporting commercialisation – Otherwise no development Need to commercialise within the industry (create value adding) – for better economic returns and incentives for implementing sustainable supply systems (cultivation, sustainable harvesting) – BASIC NEEDS PRINCIPLE Need to look to new certification, branding and trade systems to maximise the opportunities for producers – improved livelihood impacts Need to tap into existing markets (e.g. US, EU) and promote intra-Africa trade, as well as overseas trade Need to think laterally about how conservation areas can contribute to sustainable supply of medicinal plants
CURRICULUM VITAE TRAVIS W. HEIN, Ph.D. CONTACT INFORMATION TAMUSCOM Medical Research Building, Room 106E EDUCATION Postdoctoral Texas A&M University System Health Science Center. Field of Study: Training Cardiovascular Physiology, Microcirculatory Control. Mentors: Drs. Lih Kuo andMariappan Muthuchamy (September 1997-August 1999). Medical Sciences, Texas A&M University Sys
Management of neonates with (or at risk of) Herpes virus infection. (HSV+VZV) HSV Background HSV infection in the neonate is associated with high morbidity and mortality. Most commonly the infection is acquired at the time of delivery. The highest risk of infection is associated with maternal 1°inf ection due to heavier or more prolonged virus shedding particularly cervica